Michele Maffezzoli
12PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Feb 15, 2026
A prospective external validation of the GRade, Age, Nodes and Tumor score in the ECOG-ACRIN EA8143 PROSPER trial.Sebastiano Buti, Se-Eun Kim, Michele Maffezzoli
|Nov 01, 2025
Who Truly Benefits From First-Line Intensification in EGFR-Mutant NSCLC?Michele Maffezzoli, Jason Lau, Samuel Justin
|Jul 20, 2025
The Role of Circulating Tumor DNA in Patients Treated with Adjuvant Immune Checkpoint Inhibitors: Clinical Reality or Distant Horizon?Michele Maffezzoli, Ria Nagpal, Mohamed Elewaily
|Mar 25, 2025
External Validation of the GRade, Age, Nodes and Tumor (GRANT) Score for Patients with Surgically Treated Papillary Renal Cell Carcinoma.Michele Maffezzoli, Alessio Signori, Davide Campobasso
|Feb 11, 2025
Management of oligometastatic and oligoprogressive renal cell carcinoma: an updated review.Giulia Claire Giudice, Michele Maffezzoli, Irene Testi
|Jan 20, 2025
Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinations.Matilde Corianò, Alessandro Lazzarin, Michele Maffezzoli
Pageof 2
Frequent Collaborators
8 joint publications
Sebastiano Buti
2 joint publications
Giulia Claire Giudice
2 joint publications
Sara Elena Rebuzzi
2 joint publications
Fabio Catalano
2 joint publications
Alessio Signori
2 joint publications
Pasquale Rescigno
2 joint publications
Marco Maruzzo
2 joint publications
Giuseppe Luigi Banna
2 joint publications
Giuseppe Fornarini
1 joint publications
Davide Campobasso
